Introduction
D-Fenfluramine (D-Fen), a drug that increases serotonin (5-HT) content by stimulating synaptic release of serotonin and blocking its reuptake into presynaptic terminals (Rowland and Carlton, 1986) , exerts a potent anorexigenic effect in rodents and humans (McGuirk et al., 1991) . In the 1990s, D-Fen was widely prescribed and was clinically effective in the treatment of obesity. However, the drug was withdrawn from clinical use due to its adverse cardiopulmonary events (Connolly et al., 1997) . Due to the effectiveness of this drug, efforts have focused on understanding the mechanisms underlying the anorexigenic effects of D-Fen which may lead to the development of new pharmaceutical agents that mimic the appetite-suppressing property of D-Fen with fewer side effects.
The effects of D-Fen on food intake have been primarily attributed to serotonin action at 5-HT 2C receptors (5-HT 2C Rs), as the hypophagic responses induced by D-Fen are significantly blunted in 5-HT 2C R knock-out mice (Vickers et al., 1999) . 5-HT 2C R knock-out mice also display hyperphagia and a late-onset obesity (Nonogaki et al., 1998) , demonstrating that the endogenous 5-HT 2C Rs are physiological regulators of feeding and body weight.
Pro-opiomelanocortin (POMC) neurons in the arcuate nucleus of hypothalamus (ARC) express 5-HT 2C Rs (Heisler et al., 2002) and receive inputs from serotonin-immunoreactive nerve terminals (Kiss et al., 1984) . Electrophysiological studies demonstrated that serotonin and serotonergic compounds, including D-Fen, activate POMC neurons (Heisler et al., 2002; Qiu et al., 2007) . In addition, 5-HT 2C R agonists increase POMC expression in the ARC (Zhou et al., 2007; Lam et al., 2008) . We recently reported that reexpression of 5-HT 2C Rs only in POMC neurons is sufficient to rescue hyperphagia and obesity seen in mice with global 5-HT 2C R deficiency (Xu et al., 2008) . Collectively, these observations indicate that POMC neurons are a physiologically relevant target of 5-HT 2C Rs in the regulation of feeding and body weight. We hypothesize that this subpopulation of 5-HT 2C R/ POMC-expressing neurons may also be important to the appetite-suppressing effects of D-Fen. POMC neurons produce ␣-melanocyte-stimulating hormone (␣-MSH), an endogenous ligand that acts at melanocortin receptors, such as the melanocortin 4 receptors (MC4Rs) (Williams and Schwartz, 2005) . MC4Rs are widely expressed in the CNS (Mountjoy et al., 1994) . Mutations in the Mc4r/MC4R gene lead to severe hyperphagia and obesity in mice (Huszar et al., 1997) and in humans (Vaisse et al., 1998) and an insensitivity to the anorectic effect of D-Fen (Heisler et al., 2006) . Particularly, MC4Rs are abundantly expressed by SIM1 neurons in the para-ventricular nucleus of the hypothalamus (PVH) and in the amygdala (Balthasar et al., 2005) . SIM1 is a transcription factor that controls development of the PVH and mutations in Sim1/SIM1 gene produce obesity in mice and humans (Holder et al., 2000; Michaud et al., 2001) . We previously reported that restoration of MC4Rs in SIM1 neurons is sufficient to rescue hyperphagia caused by global MC4R deficiency (Balthasar et al., 2005) . Therefore, we hypothesize that D-Fen may require functional MC4Rs in SIM1 neurons to suppress feeding.
In the present study, we used several genetic mouse models to determine critical and discrete subpopulations of 5-HT 2C Rs and MC4Rs through which D-Fen influences appetite.
Materials and Methods
Animal care. All mice used were group housed with food and water available ad libitum in a temperature-controlled room with 12 h lightdark cycle in the animal facility of UT Southwestern Medical Center. Most mice were weaned on regular chow (#7001, 4% chow, Harlan Teklad). Additional cohorts of mice were weaned on high fat diet (HFD, TD.88137, 42% calories from fat, Harlan Teklad).
Mouse strains. All mice have been backcrossed (Ͼ10 generations) to the C57BL/6J background. Experiments in Figure 1 , A and B, were performed with male wild-type (WT) and 2C-null littermates in which expression of 5-HT 2C Rs is globally disrupted by a loxP-flank transcription blocker (loxTB) inserted into the X-linked Htr2c (5-HT 2C R) gene (Xu et al., 2008) . Experiments in Figure 1 , C and D, were performed with male WT, 2C-null and 2C/POMC mice. 2C/POMC male mice were hemizygous for 2C-null allele and carried the POMC-Cre transgene. In 2C/POMC mice, Cre-mediated recombination removed the loxTB and restored expression of 5-HT 2C Rs only in POMC neurons (Xu et al., 2008) .
Experiments in Figure 2 were performed with male WT, MC4R-null and MC4R/SIM1 mice. MC4R-null mice were previously generated by inserting the loxTB in the Mc4r gene (Balthasar et al., 2005) . The loxTB disrupts MC4R expression globally (Balthasar et al., 2005) . In the present study, MC4R-null mice were crossed with mice carrying the Sim1-Cre transgene (Balthasar et al., 2005) to generate MC4R/SIM1 mice, whose MC4Rs were selectively reexpressed in SIM1 neurons (Balthasar et al., 2005) . Experiments in Figure 3 , A and B, were performed with male WT and heterozygous SIM1 knock-out (SIM1 HET) littermates (Holder et al., 2004) .
Experiments in Figure 3C were performed with C57BL/6J mice maintained on regular chow or HFD.
Acute anorexigenic responses to D-Fen. After a 14 h fast (12 h dark cycle and 2 h light cycle), mice received intraperitoneal injections of saline or D-Fen (3 mg/kg, in a volume of 0.01 ml/g body weight). This dose has been demonstrated to induce hypophagia in mice without causing sedative responses and resting (Vickers et al., 1999) . Diet (chow or HFD) was provided 30 min after injections. Food intake over the next 1-2 or 1-6 h was measured. Each mouse was tested with saline and D-Fen in a counterbalanced order with 7 d between treatments.
Statistical analysis. Data are presented as mean Ϯ SEM and were analyzed with t test, one-way ANOVA followed by Student-Newman-Keuls post hoc comparisons or repeated measures (RM) ANOVA followed by LSD post hoc comparisons, where appropriate. Statistical analyses were performed with SPSS or SigmaStat software. p Ͻ 0.05 indicated statistical significance.
Results

Anorexigenic effects of D-Fen are blunted in 2C-null mice
We first performed the time course experiment to examine the efficacy of D-Fen on food intake in chow-fed WT mice and 2C-null mice. As expected, D-Fen significantly reduced 6 h food intake in WT mice ( Fig. 1A ; RM ANOVA main effect drug: F (1,7) ϭ 32.04, p Ͻ 0.001). In contrast, the anorexigenic effects of D-Fen were significantly attenuated in 2C-null mice, as D-Fen administration did not significantly alter food intake of 2C-null mice in the 6 h period (Fig. 1 B; RM ANOVA main effect drug: F (1,5) ϭ 5.96, NS). However, we observed a significant interaction between drug treatment and time in the 2C-null mice (Fig. 1 B; RM ANOVA time ϫ drug interaction: F (5,25) ϭ 8.15, p Ͻ 0.001). Specifically, while D-Fen did not alter food intake at 1, 2, 3, and 5 h in 2C-null mice, food intake was significantly reduced at 4 and 6 h after D-Fen injections. The data suggest that action at the 5-HT 2C Rs is required to mediate the acute (within the first 3 h) anorexigenic effect of D-Fen, but the longer-term effects of D-Fen on food intake are not fully dependent on 5-HT 2C R-mediated mechanisms. Importantly, it was shown that mice lacking 5-HT 2C Rs globally have comparable basal brain serotonin content as wild type mice and the mutant mice display potentiated serotonin release upon treatment of selective serotonin receptor inhibitors (e.g., fluoxetine) (Cremers et al., 2004) . Therefore, the lack of D-Fen efficacy in 2C-null mice is not likely due to impaired serotonin release, but rather to loss of 5-HT 2C R-mediated signals.
Anorexigenic effects of D-Fen are restored in 2C/POMC mice
To identify the critical 5-HT 2C R-expressing sites that mediate D-Fen anorexia, we tested the efficacy of D-Fen in WT mice, 2C-null mice and 2C/POMC mice (which selectively express 5-HT 2C Rs only in POMC neurons). Consistent with findings in Figure 1, A and B, D-Fen significantly suppressed 1 h (Fig. 1C ) and 2 h (Fig. 1 D) food intake in WT mice, but these responses were significantly blunted in 2C-null mice (Fig. 1C , one-way ANOVA F (2,20) ϭ 6.47, p Ͻ 0.01, and Fig. 1 D, one-way ANOVA F (2,20) ϭ 3.87, p Ͻ 0.05). In contrast, D-Fen significantly suppressed food intake in 2C/POMC mice, effects that were indistinguishable to those seen in WT mice (Fig. 1C,D) . Therefore, these results indicate that 5-HT 2C Rs expressed by POMC neurons are sufficient to mediate the effects of D-Fen in inhibiting acute food intake.
Anorexigenic effects of D-Fen are restored in MC4R/SIM1 mice Our observations that D-Fen anorexia is restored in mice expressing 5-HT 2C Rs in POMC neurons suggest that activation of the central melanocortin pathway underlies this compound's effect on appetite. Here we further examined this possibility by assessing whether deletion of a downstream target of ␣-MSH, the MC4Rs, abolishes the anorexigenic effect of D-Fen. As expected, D-Fen significantly decreased 6 h food intake in WT mice (Fig.  2 A; RM ANOVA main effect drug: F (1,6) ϭ 16.35, p Ͻ 0.01). In contrast, MC4R-null mice were unresponsive to D-Fen anorexia (Fig. 2 B; RM ANOVA main effect drug: F (1,9) ϭ 0.78, NS). We next examined the efficacy of D-Fen in MC4R/SIM1 mice to determine whether restoration of MC4Rs selectively in SIM1 neurons can rescue the hypophagic effect of D-Fen. The effects of D-Fen on food intake over a 6 h period were completely restored in MC4R/SIM1 mice ( Fig. 2C ; RM ANOVA main effect drug: F (1,10) ϭ 26.96, p Ͻ 0.0001). Our results therefore indicate that MC4Rs exclusively expressed by SIM1 neurons are sufficient to mediate D-Fen anorexia.
We further established the role of CNS SIM1 neurons in D-Fen hypophagia using SIM1 HET mice that lack one SIM1 allele. While D-Fen significantly decreased 6 h food intake in WT mice ( Fig. 3A ; RM ANOVA main effect drug: F (1,10) ϭ 11.99, p Ͻ 0.01), SIM1 HETS were insensitive to the anorectic effect of D-Fen ( Fig.  3B ; main effect drug: F (1,4) ϭ 0.66, NS). These results indicate that intact SIM1 function is required to mediate the complete acute anorexigenic effects of D-Fen. It is important to note that at the time of studies, MC4R-null mice, MC4R/SIM1 mice and SIM1 HET mice were significantly obese compared with their WT littermates (Table 1) . To exclude the possibility that the blunted D-Fen responses in these mice were simply due to increased body weight, we compared the efficacy of D-Fen in chow-fed lean mice and mice with HFDinduced obesity. Our results indicate that D-Fen induced similar anorexia in lean and obese mice ( Fig. 3C ; t ϭ 0.3607, df ϭ 15, NS). These findings indicate that efficacy of D-Fen-induced hypophagia is not affected by body weight per se.
Discussion
Understanding the mechanisms underlying the anorexigenic effects of D-Fen has been one of the priorities for many laboratories and pharmaceutical companies due to the potent appetitesuppressing and body weight-reducing benefits of this drug. Here we used multiple genetic mouse models to systematically assess Like the current obesity treatment sibutramine (a serotoninnorepinephrine reuptake inhibitor), D-Fen also promotes increased serotonin content in the synaptic cleft (Rowland and Carlton, 1986) . Pharmacological and genetic efforts to discern which of the 14 serotonin receptors mediates serotonin's effects on appetite indicate a primary role for the 5-HT 2C Rs (Garfield and Heisler, 2009) . Consistent with data obtained following 5-HT 2C R antagonist pretreatment and with the traditional 5-HT 2C R knock-out mouse (Vickers et al., 1999; Clifton et al., 2000) , we observed that the efficacy of D-Fen is substantially reduced in mice with global 5-HT 2C R deficiency. Together, these results indicate the necessity of the 5-HT 2C Rs in the acute effects of D-Fen on appetite.
The 5-HT 2C Rs are widely expressed in the rodent brain (Molineaux et al., 1989) , including many regions associated with food intake and energy balance. Previously, we observed that a subpopulation of 5-HT 2C Rs are anatomically positioned to influence the activity of neurons expressing POMC, the gene precursor of the potent anorectic neuropeptide and endogenous melanocortin agonist ␣-MSH (Heisler et al., 2002) . Further probing of this anatomical localization revealed that exogenous treatment with 5-HT 2C R agonists activates POMC neurons (Heisler et al., 2002; Qiu et al., 2007) and enhances POMC expression (Zhou et al., 2007; Lam et al., 2008) . Illustrating the functional relevance of this 5-HT 2C R modulation of POMC activity/expression, we observed that expression of 5-HT 2C Rs only in POMC neurons (in 2C/POMC mice) is sufficient to rescue hyperphagia and obesity seen in mice with global 5-HT 2C R deficiency (Xu et al., 2008) . Therefore, 5-HT 2C Rs expressed by POMC neurons are physiologically important in the regulation of energy homeostasis. Here we assessed whether the specific subpopulation of POMC neurons expressing 5-HT 2C Rs is also critical to mediate the hypophagic effect of D-Fen. We observed that while the reduction in food intake induced by D-Fen is attenuated in 2C-null mice, the efficacy of D-Fen is fully rescued in 2C/POMC mice. These findings indicate that 5-HT 2C Rs specifically expressed by POMC neurons are sufficient to mediate the anorexigenic effects of D-Fen.
It is worth noting that in 2C-null mice, D-Fen-induced hypophagia is only attenuated but not completely abolished. These results suggest that other 5-HT 2C R-independent mechanisms may also contribute to the anorexigenic effects of D-Fen. Since it was shown that D-Fen can potently increase noradrenalin release in the brain (Rothman et al., 2003) , it is possible that effects of D-Fen on food intake may be mediated partly by noradrenergic actions. Alternatively, our results can also be interpreted to suggest that other serotonin receptors may contribute to the effect of D-Fen on feeding. Supporting this possibility, it was shown that D-Fen-induced hypophagic responses are attenuated in 5-HT 1B R knock-out mice (Lucas et al., 1998) . Therefore, both 5-HT 2C Rs and 5-HT 1B Rs may function in concert to mediate the anorexigenic effects of D-Fen. Like 5-HT 2C Rs, 5-HT 1B Rs also act on the central melanocortin system to influence feeding. Specifically, 5-HT 1B Rs are expressed in agouti-related protein (AgRP)/neuropeptide Y (NPY) neurons (Heisler et al., 2006) , which produce the endogenous antagonist of MC4Rs, AgRP (Williams and Schwartz, 2005) . AgRP/NPY neurons also inhibit POMC neurons via the inhibitory GABAergic projections to these neurons (Tong et al., 2008) . We have previously demonstrated that 5-HT 1B R agonists directly inhibit AgRP/NPY neurons and decrease the inhibitory drive onto POMC neurons (Heisler et al., 2006) . In addition, the anorexigenic effects of 5-HT 1B R agonists are abolished in both MC4R knock-out mice and in mice with constitutive ectopic expression of the endogenous MCR antagonist, agouti peptide (Ay mice) (Heisler et al., 2006) . Collectively, these findings support the possibility that elevated 5-HT content by D-Fen may also directly act on AgRP/NPY neurons to lead to reciprocal increases in ␣-MSH release and decreases in AgRP release, which in turn would promote the suppression of food intake.
MC4Rs are widely expressed in the CNS, including many regions classically associated with food intake (Mountjoy et al., 1994) . In particular, the MC4Rs are densely expressed by SIM1 neurons in the PVH and in the amygdala (Balthasar et al., 2005) , key regions associated with appetite. Illustrating the functional importance of MC4Rs in SIM1 neurons in energy balance, restoration of MC4Rs specifically in SIM1 neurons is sufficient to rescue hyperphagia caused by global MC4R deficiency (Balthasar et al., 2005) . Here we investigated whether this important subpopulation of MC4R-expressing neurons also underlies the effects of D-Fen on appetite. We observed that selective reactivation of MC4Rs only in SIM1 neurons is sufficient to restore the efficacy of D-Fen which is otherwise abolished in MC4R-null mice. The anorexigenic effects of D-Fen were also abolished in mice heterozygous for Sim1-null allele. These findings indicate that the hypophagic effects of D-Fen are mediated by MC4Rs expressed by SIM1 neurons.
In summary, we used several unique genetic mouse models to demonstrate that the 5-HT 2C R-MC4R circuit in the brain is sufficient to mediate actions by D-Fen to reduce food intake. Together, the data support the following model: elevated serotonin induced by D-Fen activates POMC neurons via 5-HT 2C Rs, and POMC neurons secrete ␣-MSH, which in turn acts on MC4Rs expressed by SIM1 neurons to inhibit appetite. It is important to consider that our findings do not demonstrate that this 5-HT 2C R-MC4R circuit is the only pathway that mediates the effect of D-Fen on food intake, as the genetic mouse lines used (2C/POMC and MC4R/SIM1 mice) do not determine whether this circuit is also required for the effects of D-Fen. In fact, both 5-HT 2C Rs (Molineaux et al., 1989) and MC4Rs (Mountjoy et al., 1994) are also expressed in other brain regions that may provide redundant pathways mediating the anorexigenic effects of D-Fen. The potential physiological relevance of these possible redundant 5-HT 2C R or MC4R sites has yet to be characterized.
Here we describe a discrete pathway through which one of the most clinically effective pharmacological obesity treatments influences appetite-via 5-HT 2C Rs expressed with POMC neurons that influence the activity of MC4Rs expressed in SIM1 neurons. This pathway is critical for normal energy balance since restoration of 5-HT 2C Rs or MC4Rs in these specific subsets of chemically defined neurons is sufficient to normalize aberrant feeding behavior. Collectively, these data suggest that selective therapeutic targets to this 5-HT 2C R/POMC-MC4R/SIM1 circuit may provide a discrete and effective treatment for obesity.
